Etablissements Maurel et Prom SA (MAU)
Euronext Paris · France · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 8.110 |
|---|---|
| 52-week range | 4.532 – 11.440 |
| Return, 1 month / 3 months | +0.6% / +4.2% |
| Return, 1 year / 3 years | +80.3% / +75.5% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 42.5% |
| Worst drawdown (1 year) | -33.4% |
| Average daily value traded | 1.57M EUR |
| Dividend yield | 4.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Etablissements Maurel et Prom is an independent oil and gas company based in Paris, France. It explores for, develops and produces crude oil and natural gas, and holds working interests in producing fields and exploration acreage, chiefly in Gabon and other parts of Africa. Its customers are the buyers of its crude oil and natural gas output, and it works alongside national oil companies and partners in the countries where its assets are located.
Etablissements Maurel et Prom SA trades under the code MAU on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Etablissements Maurel et Prom SA (MAU) trades on the Euronext Paris in France. It last closed at EUR 8.110 on 27 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 177 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 80.3% and over the last three months it rose 4.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.8% | ||
| From 52-week high | -29.1% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.2% | ||
| 6-month return | -10.3% | ||
| 12-month return, skipping the last month | 79.3% | ||
| Stability (higher is calmer) | 50 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 42.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.4% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 1.57M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.7% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | +0.6% |
| 3 months | +4.2% |
| 6 months | −10.3% |
| 1 year | +80.3% |
| 3 years | +75.5% |
| 5 years | +306.1% |
Signals
| 50-day / 200-day average | 8.067 / 8.263 |
|---|---|
| Golden / death cross (60 days) | Death, 20 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.238 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Aug 2026 | EUR 0.3800 |
| 26 Aug 2025 | EUR 0.3300 |
| 3 Jul 2024 | EUR 0.3000 |
| 3 Jul 2023 | EUR 0.2300 |
| 1 Jul 2022 | EUR 0.1400 |
| 17 Jun 2019 | EUR 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.